AAVLife aimed at advancing gene therapy for cardiomyopathy in Friedreich’s ataxia to clinic

AAVLife aimed at advancing gene therapy for cardiomyopathy in Friedreich’s ataxia to clinic. International collaboration advances gene therapy for Friedreich’s ataxia

DOWNINGTOWN, Pa., April 6, 2014 /PRNewswire-USNewswire/ — The Friedreich’s Ataxia Research Alliance (FARA) is pleased to recognize the ground-breaking gene-therapy research of FARA-funded scientist Dr. Hélène Puccio.

FARA Press Release:
International collaboration advances gene therapy for Friedreich’s ataxia; AAVLife aimed at advancing gene therapy for cardiomyopathy in Friedreich's ataxia to clinic